BioCentury
ARTICLE | Company News

BresaGen, Opsona deal

August 8, 2005 7:00 AM UTC

BGN will use its protEcol Services technology to conduct feasibility studies and process development for the planned large-scale cGMP manufacture of Opsona's recombinant OPN-201 in E. coli. The im-mun...